Cardiac Rhythm Management Devices Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cardiac Rhythm Management Devices Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cardiac rhythm management (CRM) is the treatment of arrhythmias (heart rhythm disorders) or atrial fibrillation (AF). Arrhythmias can cause a range of problems for patients, from palpitations and dizzy spells to sudden cardiac arrest. Cardiac rhythm management devices such as pacemakers, cardiac resynchronization therapy (CRT) devices and implantable cardiac defibrillators (ICDs) continue to evolve rapidly in reliability and lifespan. Most CRM devices are implanted under the skin, with one to three leads threaded down a vein to connect to the heart.
Market Dynamics
Increasing incidences of heart failure and arrhythmia have fuelled rapid advancements in cardiac rhythm management (CRM) technologies eventually increasing the demand for CRM devices. According to the study published in 2016, by the Journal of the Formosan Medical Association, around 72 million people are estimated to suffer from atrial fibrillation in Asia by 2050, which is expected to be more than double the combined numbers of patients from the U.S. and Europe.
However, factors such as chances of infections associated with installation of pacemakers in cardiac patients can hamper the cardiac rhythm management devices market growth. Pacemaker surgery can also led to various complications such as bleeding, bruising or swelling at the of area of pacemaker implantation leading to blood vessel or nerve damage, which in turn can reduce adoption of cardiac implants in patients.
Key features of the study:
This report provides in-depth analysis of the cardiac rhythm management devices market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global cardiac rhythm management devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Medtronic plc, Abbott Laboratories, Abiomed, Boston Scientific Corporation, Biotronik Se Co Kg, Koninklijke Philips N.V., LivaNova Plc, Cardiac Science Corporation, Schiller Ag, and Zoll Medical Corporation
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global cardiac rhythm management devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for cardiac rhythm management devices market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Cardiac Rhythm Management Devices Market, By Product Type:
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Defibrillator
Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators
Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Biventricular Pacemakers
Global Cardiac Rhythm Management Devices Market, By End User:
Hospital
Home Care Settings
Ambulatory Care Settings
Global Cardiac Rhythm Management Devices Market, By Region:
North America
By Country:
U.S.
Canada
By Product Type:
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Defibrillator
Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators
Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Biventricular Pacemakers
By End User:
Hospital
Home Care Settings
Ambulatory Care Settings
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Defibrillator
Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators
Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Biventricular Pacemakers
By End User:
Hospital
Home Care Settings
Ambulatory Care Settings
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Defibrillator
Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators
Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Biventricular Pacemakers
By End User:
Hospital
Home Care Settings
Ambulatory Care Settings
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Defibrillator
Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators
Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Biventricular Pacemakers
By End User:
Hospital
Home Care Settings
Ambulatory Care Settings
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Defibrillator
Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators
Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Biventricular Pacemakers
By End User:
Hospital
Home Care Settings
Ambulatory Care Settings
Africa
By Country:
South Africa
Central Africa
North Africa
By Product Type:
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Defibrillator
Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators
Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Biventricular Pacemakers
By End User:
Hospital
Home Care Settings
Ambulatory Care Settings
Company Profiles
Medtronic plc*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Abbott Laboratories
Abiomed
Boston Scientific Corporation
Biotronik Se Co Kg
Koninklijke Philips N.V.
LivaNova Plc
Cardiac Science Corporation
Schiller Ag
Zoll Medical Corporation
“*” marked represents similar segmentation in other categories in the respective section.